Frontier Capital Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.8M Buy
1,853,183
+761,655
+70% +$15.2M 0.36% 105
2026
Q2
$24.6M Buy
1,091,528
+481,671
+79% +$12.1M 0.23% 165
2026
Q1
$15.3M Buy
609,857
+375,677
+160% +$10.6M 0.16% 192
2025
Q4
$7.37M Buy
234,180
+128,712
+122% +$4.27M 0.08% 258
2025
Q3
$3.76M Sell
105,468
-313,190
-75% -$14.3M 0.03% 278
2025
Q2
$24.1M Buy
418,658
+203,602
+95% +$11.5M 0.22% 166
2025
Q1
$12.5M Sell
215,056
-10,296
-5% -$703K 0.14% 200
2024
Q4
$18.1M Buy
+225,352
New +$19.3M 0.17% 176

Other funds holding PRCT

Frontier Capital Management's PRCT Position: Q3 2026 in Review

Frontier Capital Management increased its Procept Biorobotics (PRCT) stake by 70% in Q3 2026, buying an estimated $15.2M and bringing the position to 1,853,183 shares worth $33.8M. The position accounts for 0.36% of the portfolio, ranked #105.

Frontier Capital Management first reported a position in PRCT in Q4 2024 and has held it in 8 quarters since. 225 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Frontier Capital Management held 1,853,183 shares of Procept Biorobotics worth $33.8M as of Q3 2026.
  • Frontier Capital Management bought 761,655 Procept Biorobotics shares in Q3 2026, an estimated $15.2M.
  • Procept Biorobotics made up 0.36% of Frontier Capital Management's portfolio in Q3 2026, its #105 holding.
  • Frontier Capital Management first reported a position in Procept Biorobotics in Q4 2024 and has held it in 8 quarters since.
  • 225 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.